Pfizer seeking Schick buyer
This article was originally published in The Rose Sheet
Executive Summary
Pfizer announces it is "exploring strategic options," including possible sale, for its Schick-Wilkinson Sword shaving products and Adams confectionery businesses. With 2001 sales of approximately $620 mil., Schick's top brands include Xtreme III razors and blades, Silk Effects, Protector and FX Diamonds. Both the Schick and Adams businesses became part of Pfizer in June 2000 with the company's merger with Warner-Lambert. Morgan Stanley will act as investment banker for Schick...
You may also be interested in...
BIC won’t get Schick
BIC out of running for Pfizer's Schick-Wilkinson shaving business due to possible regulatory hurdles, BIC announces Sept. 3. BIC contacted Pfizer after shaving business was put up for sale, but the pharmaceutical giant said it would not pursue a deal with BIC because it would take longer to obtain regulatory approval than if it proceeded with other potential buyers, BIC says. BIC will move forward with plans to enter triple-blade razor category with scheduled launch of BIC Comfort 3 Shaver in first quarter 2003, firm adds. Pfizer announced its desire to divest Schick in June (1"The Rose Sheet" July 1, 2002, In Brief)...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.